Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosis

24 Jul 2024

Abstract excerpt

PURPOSE OF REVIEW: Antinuclear autoantibodies represent a serological hallmark of systemic sclerosis (SSc), with anticentromere, antitopoisomerase-I, and anti-RNA polymerase III antibodies routinely assessed for diagnosis, clinical subset classification, and prognosis. In addition, an increasing number of autoantibodies have been demonstrated to play a pathogenic role by mediating different SSc manifestations....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Multiple Sclerosis Research Studies
Share to Systemic Lupus Erythematosus Research
Share to Systemic Sclerosis and Related Diseases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39046085
DOI: 10.1097/bor.0000000000001035

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autoantibodies as putative biomarkers and triggers of cell dysfunctions in systemic sclerosisPMID 39046085Read ↗

An update on autoantibodies in scleroderma.Semantic proximity Read ↗

Scleroderma: the role of serum autoantibodies in defining specific clinical phenotypes and organ system involvement.Semantic proximity Read ↗

Combinations of scleroderma hallmark autoantibodies associate with distinct clinical phenotypes.Semantic proximity Read ↗

Disease-related autoantibody profile in patients with systemic sclerosisSemantic proximity Read ↗

Clinical significance of autoantibodies in dermatomyositis and systemic sclerosis.Semantic proximity Read ↗

The Evolving Landscape of Systemic Sclerosis Pathogenesis: From Foundational Mechanisms to Organ-Specific ModifiersSemantic proximity Read ↗

Autoantibodies against small nucleolar ribonucleoprotein complexes and their clinical associationsSemantic proximity Read ↗

Evaluation of particle-based multi-analyte technology for autoantibody detection in systemic sclerosis: concordance with conventional methods and clinical associations.Semantic proximity Read ↗

The Clinical Value of Autoantibodies in Rheumatoid ArthritisSemantic proximity Read ↗

Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.Semantic proximity Read ↗

Autoantibodies Against DFS70/LEDGF Exclusion Markers for Systemic Autoimmune Rheumatic Diseases (SARD)Semantic proximity Read ↗

Emerging Blood Biomarkers in Systemic Sclerosis: From Single Molecules to Biomarker-Based Patient StratificationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.